Sotac Pharmaceuticals Limited (NSE:SOTAC)

India · Delayed Price · Currency is INR

90.05

0.00 (0.00%)

Aug 20, 2026, 11:13 AM IST

-27.96% (1Y)

Market Cap	995.05M -28.0%
Revenue (ttm)	1.02B +1.3%
Net Income	57.67M -28.2%
EPS	5.22 -28.1%
Shares Out	11.05M
PE Ratio	17.25
Forward PE	n/a
Dividend	0.20 (0.23%)
Ex-Dividend Date	Sep 19, 2025

Volume	1,200
Open	90.05
Previous Close	90.05
Day's Range	90.05 - 90.05
52-Week Range	86.00 - 139.65
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products. The compan... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2014

Employees 127

Stock Exchange National Stock Exchange of India

Ticker Symbol SOTAC

Full Company Profile

Financial Performance

In fiscal year 2026, Sotac Pharmaceuticals's revenue was 1.02 billion, an increase of 1.33% compared to the previous year's 1.00 billion. Earnings were 57.67 million, a decrease of -28.16%.

Financial Statements